Cargando…

Economic Burden of Metastatic Ovarian Cancer in a Commercially Insured Population: A Retrospective Cohort Analysis

BACKGROUND: Ovarian cancer is the tenth most common type of cancer and the fifth leading cause of cancer death among females in the United States. The majority of incident ovarian cancer cases are diagnosed in individuals aged < 65 years, but limited evidence exists regarding the economic burden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chin, Lauren, Hansen, Ryan N., Carlson, Josh J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391014/ https://www.ncbi.nlm.nih.gov/pubmed/32715961 http://dx.doi.org/10.18553/jmcp.2020.26.8.962

Ejemplares similares

Economic Burden of HIV in a Commercially Insured Population in the United States
por: Chen, Cindy Y., et al.
Publicado: (2023)

Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis
por: Placzek, Hilary, et al.
Publicado: (2015)

Economic Burden of Irritable Bowel Syndrome with Constipation: A Retrospective Analysis of Health Care Costs in a Commercially Insured Population
por: Doshi, Jalpa A., et al.
Publicado: (2014)

Economic Burden of Anemia in an Insured Population
por: Nissenson, Allen R., et al.
Publicado: (2005)

Economic burden of interstitial lung disease in a commercially insured population with Sjögren syndrome in the United States
por: Lee, Tsung-Ying, et al.
Publicado: (2022)

Clinical and economic burden of prescribing tramadol and other opioids for patients with osteoarthritis in a commercially insured population in the United States
por: Silverman, Stuart, et al.
Publicado: (2022)

The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States
por: Sacks, Naomi C., et al.
Publicado: (2022)

2145. Economic Burden of Congenital Cytomegalovirus Infection in Commercially- and Medicaid-insured Patients in the United States
por: Diaz-Decaro, John D, et al.
Publicado: (2022)

Economic burden related to fistulas or strictures among commercially insured patients with Crohn’s disease in the United States
por: Fan, Yanni, et al.
Publicado: (2023)

Economic burden of acute steroid-refractory graft-versus-host disease in commercially insured pediatric patients
por: Grabner, Michael, et al.
Publicado: (2021)

Real-world treatment patterns and economic burden of post-cataract macular edema
por: Ahmadyar, Gina, et al.
Publicado: (2023)

Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study
por: Jeffery, Molly Moore, et al.
Publicado: (2018)

Research on the Effect of Commercial Health Insurance Development on Economic Efficiency
por: Zhao, Tongpu, et al.
Publicado: (2023)

Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
por: Mostaghimi, Arash, et al.
Publicado: (2022)

Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans
por: Lam, Carolyn S. P., et al.
Publicado: (2021)

Associations of Renin‐Angiotensin System Antagonist Medication Adherence and Economic Outcomes Among Commercially Insured US Adults: A Retrospective Cohort Study
por: Campbell, Patrick J., et al.
Publicado: (2020)

Retrospective Analysis of the Burden of Illness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Versus Asthma in Commercially Insured US Patients
por: Bell, Christopher F, et al.
Publicado: (2023)

Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis
por: Zhou, Zhou, et al.
Publicado: (2019)

Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population
por: Lin, David, et al.
Publicado: (2021)

Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance
por: Cham, Stephanie, et al.
Publicado: (2022)

Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States
por: Lu, Mei, et al.
Publicado: (2021)

Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
por: Elsaid, Mohamed I., et al.
Publicado: (2020)

Health economic burden of patients with phenylketonuria (PKU) – A retrospective study of German health insurance claims data
por: Trefz, Friedrich, et al.
Publicado: (2021)

Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population
por: Chung, Haechung, et al.
Publicado: (2023)

A retrospective study of HIV antiretroviral treatment persistence in a commercially insured population in the United States
por: Juday, Timothy, et al.
Publicado: (2011)

Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective Analysis
por: Giles, Jon T., et al.
Publicado: (2021)

The Impact of Health Insurance on Economic Burden for Hepatitis B Inpatients in China
por: ZHANG, Hua, et al.
Publicado: (2016)

Care Among Migraine Patients in a Commercially Insured Population
por: Bonafede, Machaon, et al.
Publicado: (2020)

Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population
por: Law, Amy, et al.
Publicado: (2016)

Burden of vaccine-preventable disease in adult Medicaid and commercially insured populations: Analysis of claims-based databases, 2006–2010
por: Krishnarajah, Girishanthy, et al.
Publicado: (2014)

The Economic Impact of Living Cell Tissue Products in Treating Diabetic Foot Ulcers and Venous Leg Ulcers in Patients with Commercial Insurance: A Retrospective Matched-Cohort Study
por: Barbul, Adrian, et al.
Publicado: (2023)

Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population
por: Mattingly, T. Joseph, et al.
Publicado: (2019)

The Economic Burden of Clostridioides difficile in Denmark: A Retrospective Cohort Study
por: Braae, Uffe Christian, et al.
Publicado: (2020)

Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study
por: Margolis, Jay M, et al.
Publicado: (2011)

Incidence of venous thrombotic events and events of special interest in a retrospective cohort of commercially insured US patients
por: Weller, Susan C, et al.
Publicado: (2022)

Alcohol-Attributable Medical Costs in Commercially Insured and Medicaid Populations
por: Ozluk, Pelin, et al.
Publicado: (2022)

Cost Burden of Endothelial Keratoplasty in Fuchs Endothelial Dystrophy: Real-World Analysis of a Commercially Insured US Population (2014–2019)
por: Dhaliwal, Deepinder K, et al.
Publicado: (2022)

Economic burden associated with chronic constipation in Sweden: a retrospective cohort study
por: Bruce Wirta, Sara, et al.
Publicado: (2014)

Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study
por: Raimundo, Karina, et al.
Publicado: (2016)

Clinical And Economic Burden Of Eosinophilic COPD In A Large Retrospective US Cohort
por: Trudo, Frank, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tlcdgk6aucbf1mm31tdludfc9m